BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FXYD4
,
cell-cell adhesion
,
Arthritis
,
Leukocyte
,
Avian flu virus
,
Acetaminophen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphodiesterase iii
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
A comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant …
Minimally invasive monitoring of skeletal muscle hypermetabolism induced by the phosphodiesterase-II…
Milrinone, a phosphodiesterase III inhibitor, prevents reduction of jugular bulb saturation during r…
Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect…
Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive d…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy…
Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Dis…
FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Ph…
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodieste…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ